Wednesday, April 25, 2018
 
 
Company News: Page (1) of 1 - 01/11/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
HedgePath Pharmaceuticals Secures New Funding from Mayne Pharma to Support BCCNS Clinical and Regulatory Approval Programs
HPPI receives three tranche preferred stock and warrant funding, with $2.4 million upfront, $1.6 million by mid-2018, and an additional $1 million by year end if BCCNS NDA is acceptedHPPI's Supply...
(January 11, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA, Inc.,Science,Communications Technology,Medical,Cancer,Business,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,  
 
 
 
 
 
 
 
Seniors

Drugs

Cancer
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines